CIK 0001604821 · Large accelerated filer
Natera, Inc.
Sign in to watch- Ticker
- NTRA
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 010894487
- Phone
- 650-249-9090
- Business address
- 13011 MCCALLEN PASS, BUILDING A SUITE 100, AUSTIN, TX, 78753
- Former names
- Natera, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $104,832,418
- in 28 filings, $104.8M under 10b5-1 plans
Net −$104,832,418. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Rabinowitz Matthew −$72.3M EXECUTIVE CHAIRMAN sold 9% of stake
- Sheena Jonathan −$13.8M Director sold 83% of stake
- Moshkevich Solomon −$9.5M PRESIDENT, CLINICALDIAGNOSTICS sold 21% of stake
- Chapman Steven Leonard −$5.0M CEO AND PRESIDENT sold 12% of stake
- Brophy Michael Burkes −$2.5M CHIEF FINANCIAL OFFICER sold 11% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-01 | BOTHA ROELOF Director | Sale | −26,411 | $218.69 | $5.8M | 1,127,787 |
| 2026-06-01 | BOTHA ROELOF Director | Sale | −10,100 | $219.78 | $2.2M | 1,117,687 |
| 2026-06-01 | BOTHA ROELOF Director | Sale | −21,304 | $220.94 | $4.7M | 1,096,383 |
| 2026-06-01 | BOTHA ROELOF Director | Sale | −14,885 | $221.58 | $3.3M | 1,081,498 |
| 2026-06-01 | BOTHA ROELOF Director | Sale | −2,850 | $222.79 | $635K | 1,078,648 |
| 2026-06-01 | BOTHA ROELOF Director | Sale | −2,450 | $223.83 | $548K | 1,076,198 |
| 2026-05-29 | Rubin Eric H Director | Grant or award | +2,124 | 2,129 | ||
| 2026-05-26 | Fesko John PRESIDENT, CHIEF BUS. OFFICER | Sale 10b5-1 | −1,438 | $202.84 | $292K | 185,782 |
| 2026-05-26 | Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS | Sale 10b5-1 | −1,652 | $202.84 | $335K | 140,643 |
| 2026-05-13 | Sheena Jonathan Director | Sale 10b5-1 | −85 | $199.52 | $17K | 20,197 |
| 2026-05-13 | Sheena Jonathan Director | Sale 10b5-1 | −345 | $201.11 | $69K | 19,852 |
| 2026-05-13 | Sheena Jonathan Director | Sale 10b5-1 | −290 | $202.58 | $59K | 19,562 |
| 2026-05-13 | Sheena Jonathan Director | Sale 10b5-1 | −30 | $202.84 | $6K | 19,532 |
| 2026-05-13 | Sheena Jonathan Director | Sale 10b5-1 | −96 | $199.43 | $19K | 20,186 |
| 2026-05-13 | Sheena Jonathan Director | Sale 10b5-1 | −360 | $201.19 | $72K | 19,826 |
| 2026-05-13 | Sheena Jonathan Director | Sale 10b5-1 | −285 | $202.68 | $58K | 19,541 |
| 2026-05-13 | Sheena Jonathan Director | Sale 10b5-1 | −9 | $203.30 | $2K | 19,532 |
| 2026-05-08 | Sheena Jonathan Director | Sale 10b5-1 | −200 | $205.43 | $41K | 255,452 |
| 2026-05-08 | Sheena Jonathan Director | Sale 10b5-1 | −900 | $207.24 | $187K | 254,552 |
| 2026-05-08 | Sheena Jonathan Director | Sale 10b5-1 | −700 | $208.13 | $146K | 253,852 |
Page 18 of 39 · 767 trades